Open access · CC-BY
via OpenAlex
Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions
Anna L. Kamdar, Robert Sykes, Cameron R. Thomson, Kenneth Mangion, Daniel Tze Yee Ang, Michelle AW Lee, Tom Van Agtmael, Colin Berry
Infectious Medicine · 2024 · ▲ 5 citations
Abstract
• COVID-19 research could be applicable to and inform on other post-viral syndromes and respiratory illnesses. • Histopathological evidence of increased collagen deposition, abnormal CMR findings and upregulated extracellular matrix remodelling related pathways suggests that systemic, and vascular inflammation, may contribute to symptom burden in post-COVID-19 syndromes. • Identification of candidate target pathways remains a challenge in myocarditis patients due to the complexity of presentation and lack of prospective tissue collection. • Trials are needed to provide clinical and scientific evidence to inform treatment decisions in post-COVID-19 syndromes. Causal associations between viral infections and acute myocardial injury are not fully understood, with mechanisms potentially involving direct cardiovascular involvement or systemic inflammation. This review explores plausible mechanisms of vascular fibrosis in patients with post-COVID-19 syndrome, focusing on extracellular matrix remodelling. Despite global attention, significant mechanistic or translational breakthroughs in the management of post-viral syndromes remain limited. No effective pharmacological or non-pharmacological interventions are currently available for patients experiencing persistent symptoms following COVID-19 infection. The substantial expansion of scientific knowledge resulting from collaborative efforts by medical experts, scientists, and government organisations in undertaking COVID-19 research could inform treatment strategies for other post-viral syndromes and respiratory illnesses. There is a critical need for clinical trials to evaluate potential therapeutic candidates, providing evidence to guide treatment decisions for post-COVID-19 syndromes. Central illustration
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.imj.2024.100147
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Kamdar, A.L., Sykes, R., Thomson, C.R., Mangion, K., Ang, D.T.Y., Lee, M.A., Agtmael, T.V., & Berry, C. (2024). Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions. <em>Infectious Medicine</em>. https://doi.org/10.1016/j.imj.2024.100147
Vancouver
Kamdar AL, Sykes R, Thomson CR, Mangion K, Ang DTY, Lee MA, et al. Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions. Infectious Medicine. 2024. doi:10.1016/j.imj.2024.100147.
BibTeX
@article{anna2024Vascul,
title = {Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions},
author = {Anna L. Kamdar and Robert Sykes and Cameron R. Thomson and Kenneth Mangion and Daniel Tze Yee Ang and Michelle AW Lee and Tom Van Agtmael and Colin Berry},
journal = {Infectious Medicine},
year = {2024},
doi = {10.1016/j.imj.2024.100147},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Endocrinology 2025
Open access · CC-BY
Editorial: Circadian rhythm in adrenal endocrinology
Frontiers in microbiology 2026
Open access · OA
Gut microbiome-immune-metabolic mechanisms in cerebrovascular disease: evidence-graded insights from cerebral small vessel disease, ischemic stroke, and intracerebral hemorrhage.
Stroke 2022
Citation only
Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword
Matrix Biology 2024
Citation only
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
GeroScience 2026
Open access · CC-BY
Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization
GeroScience 2026
Open access · OA